Demographic and Clinical Characteristics of Patients Who Had Vitamin D Testing in 2015
| Characteristic | Patients Who Had Vitamin D Test with Indication (N = 7468)* | Nonindicated Vitamin D Test Subset (N = 574)* |
|---|---|---|
| Age (years) | ||
| Means (range) | 65.7 ± 13.5 (19.8 to 101.3) | 56.9 ± 11.1† (19.9 to 95.3) |
| 18 to 29.9 | 55 (0.7%) | 20 (3.5%) |
| 30 to 39.9 | 244 (3.3%) | 54 (9.4%) |
| 40 to 49.9 | 658 (8.8%) | 104 (18.1%)‡ |
| 50 to 59.9 | 1388 (18.6%) | 165 (28.7%)‡ |
| 60 to 69.9 | 2154 (28.8%) | 126 (22.0%)§ |
| 70 to 79.9 | 1884 (25.2%) | 68 (11.8%)‡ |
| 80 to 89.9 | 949 (12.7%) | 31 (5.4%)§ |
| 90 to 99.9 | 135 (1.8%) | 6 (1.0%) |
| >100 | 1 (0.1%) | 0 (0.0%) |
| Sex | ||
| Male | 1779 (23.8%) | 227 (39.5%)‡ |
| Female | 5689 (76.2%) | 347 (60.5%)‡ |
| Race/ethnicity | ||
| White | 6792 (90.9%) | 526 (91.6%) |
| Black | 522 (7.0%) | 35 (6.1%) |
| Asian | 53 (0.7%) | 3 (0.5%) |
| Hispanic | 22 (0.3%) | 2 (0.3%) |
| Other | 79 (1.1%) | 8 (1.4%) |
| BMI (kg/m2) | ||
| Overall mean (range) | 30.1 ± 7.5‖ (9.9 to 74.4) | 30.7 ± 9.0¶ (17.2 to 56.8) |
| <18.5 | 73 (1.9%) | 1 (0.3%) |
| 18.5 to 24.9 | 899 (23.0%) | 70 (22.4%) |
| 25.0 to 29.9 | 1252 (32.1%) | 99 (31.7%) |
| 30.0 to 34.9 | 873 (22.4%) | 71 (22.8%) |
| 35.0 to 39.9 | 418 (10.7%) | 44 (14.8) |
| >40.0 | 388 (9.9%) | 27 (8.7) |
| Insurer | ||
| Medicare | 3564 (47.7%) | 98 (17.1%)† |
| Medicaid | 108 (1.4%) | 12 (2.1%) |
| Commercial | 2092 (28.0%) | 240 (41.8%)‡ |
| Self-pay | 1675 (22.4%) | 220 (38.3%)† |
| Other | 29 (0.38%) | 4 (0.70%) |
| Top 5 diagnoses associated with vitamin D test | ||
| Vitamin D deficiency: 4202 (56.3%) Osteoporosis/osteopenia: 2276 (30.5%) Chronic kidney disease: 336 (4.5%) Malabsorption: 300 (4.0%) Fracture: 24 (0.3%) | Fatigue: 274 (48%) Wellness exam/screening: 113 (20%) Pain: 90 (16%) Rheumatological condition: 28 (5%) Depression: 25 (4%) |